United States Central Venous Catheters Market Outlook to 2023

  • ID: 4339012
  • Report
  • Region: United States
  • 68 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard Inc
  • Edwards Lifesciences Corp
  • Smiths Medical
  • Teleflex Inc
  • MORE
United States Central Venous Catheters Market Outlook to 2023

Summary

The author’s new report, "United States Central Venous Catheters Market Outlook to 2023", provides key market data on the United States Central Venous Catheters market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Antimicrobial Central Venous Catheters, Non Antimicrobial Central Venous Catheters and PICC (Peripherally Inserted Central Catheter) Lines.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Central Venous Catheters market segments - Antimicrobial Central Venous Catheters, Non Antimicrobial Central Venous Catheters and PICC (Peripherally Inserted Central Catheter) Lines.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Central Venous Catheters market.
  • Key players covered include Teleflex Inc, C. R. Bard Inc, Edwards Lifesciences Corp and B. Braun Melsungen AG.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard Inc
  • Edwards Lifesciences Corp
  • Smiths Medical
  • Teleflex Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Central Venous Catheters Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Central Venous Catheters Market, United States
3.1 Central Venous Catheters Market, United States, Revenue ($m), 2009-2016
3.2 Central Venous Catheters Market, United States, Revenue ($m), 2016-2023
3.3 Central Venous Catheters Market, United States, Volume (Units), 2009-2016
3.4 Central Venous Catheters Market, United States, Volume (Units), 2016-2023
3.5 Central Venous Catheters Market, United States, Average Price ($), 2009-2023
3.6 Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), 2015-2016
3.7 Central Venous Catheters Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Central Venous Catheters Market
4.1 Teleflex Inc
4.1.1 Company Overview
4.2 C. R. Bard Inc
4.2.1 Company Overview
4.3 Edwards Lifesciences Corp
4.3.1 Company Overview
4.4 B. Braun Melsungen AG
4.4.1 Company Overview
4.5 Smiths Medical
4.5.1 Company Overview
5 Central Venous Catheters Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 PAVmed Raises USD5 Million in Private Placement of Notes and Warrants
6.1.2 Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019
6.1.3 Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020
6.1.4 Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022
6.1.5 Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022
6.1.6 Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024
6.1.7 Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027
6.1.8 Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047
6.1.9 Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019
6.1.10 Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million
6.1.11 Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million
6.2 Equity Offerings
6.2.1 Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares
6.2.2 Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares
6.2.3 PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants
6.2.4 PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units
6.2.5 PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units
6.2.6 PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants
7 Recent Developments
7.1 Corporate Communications
7.1.1 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President
7.1.2 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer
7.1.3 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer
7.1.4 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors
7.2 Financial Announcements
7.2.1 May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update
7.2.2 May 10, 2017: ICU Medical Announces First Quarter 2017 Results
7.2.3 May 04, 2017: Teleflex Reports First Quarter 2017 Results
7.2.4 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter
7.2.5 Apr 03, 2017: Retractable Technologies Reports Results for the Year 2016
7.2.6 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results
7.2.7 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance
7.2.8 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter
7.2.9 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016
7.2.10 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results
7.2.11 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
7.2.12 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results
7.2.13 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update
7.2.14 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016
7.2.15 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results
7.2.16 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter
7.2.17 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results
7.3 Government and Public Interest
7.3.1 Jun 06, 2017: BD Releases 2016 Sustainability Report
7.3.2 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management
7.4 Legal And Regulatory
7.4.1 Mar 21, 2017: Retractable Technologies Announces Litigation Updates
7.4.2 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016
Table 4: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023
Table 5: Central Venous Catheters Market, United States, Average Price ($), Historic, 2009-2016
Table 6: Central Venous Catheters Market, United States, Average Price ($), Forecast, 2016-2023
Table 7: Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 8: Central Venous Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Central Venous Catheters Market Pipeline Products
Table 10: PAVmed Raises USD5 Million in Private Placement of Notes and Warrants
Table 11: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019
Table 12: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020
Table 13: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022
Table 14: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022
Table 15: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024
Table 16: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027
Table 17: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047
Table 18: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019
Table 19: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million
Table 20: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million
Table 21: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares
Table 22: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares
Table 23: PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants
Table 24: PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units
Table 25: PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units
Table 26: PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants

List of Figures
Figure 1: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016
Figure 4: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023
Figure 5: Central Venous Catheters Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teleflex Inc
  • C. R. Bard Inc
  • Edwards Lifesciences Corp
  • B. Braun Melsungen AG
  • Smiths Medical
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll